Upregulation of miR-210 and miR-21 and downregulation of miR-126 expression are potential CRC biomarkers because of their participation in HIF-1α/VEGF signaling during the initiation of colon cancer. The gene discussed is HIF1A; the disease is colonic neoplasm.